tovorafenib
day one biopharmaceutical
['trigger', 'tovorafenib']
$dawn
#aacr23
session po.cl09.02 - molecular targeted therapies 1
3414 / 24 - the pan-raf inhibitor tovorafenib suppresses nf1-mutant glioma through upregulation of foxo1 and triggering of oncogene-induced senescence
april 17, 2023, 1:30 pm-5:00 pm
$eras 